EDITAS MEDICINE INC.
3.1490
07-November-24 11:28:45
15 minutes delayed
Stocks
-0.1310
-3.99%
Today's range
3.1100 - 3.3000
ISIN
N/A
Source
NASDAQ
-
19 Jan 2023 07:00:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Strategic Updates and Portfolio Reprioritization
09 Jan 2023 08:15:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Present at the 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 06:30:00 By Nasdaq GlobeNewswire
-
06 Dec 2022 06:30:00 By Nasdaq GlobeNewswire
-
01 Dec 2022 16:01:00 By Nasdaq GlobeNewswire
-
17 Nov 2022 07:15:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Third Quarter 2022 Results and Business Updates
02 Nov 2022 06:30:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing Third Quarter 2022 Results and Corporate Update
26 Oct 2022 06:30:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Participate in Upcoming Investor Conferences
01 Sep 2022 06:30:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Second Quarter 2022 Results and Business Updates
03 Aug 2022 06:29:00 By Nasdaq GlobeNewswire
-
27 Jul 2022 06:30:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing Second Quarter 2022 Results and Corporate Updates
26 Jul 2022 06:26:00 By Nasdaq GlobeNewswire
-
Editas Medicine Reports Inducement Grant to New Chief Medical Officer
20 Jul 2022 16:30:00 By Nasdaq GlobeNewswire
-
Editas Medicine Appoints Baisong Mei, M.D., Ph.D., as Chief Medical Officer
18 Jul 2022 07:00:00 By Nasdaq GlobeNewswire
-
Editas Medicine Reports Inducement Grants to New Chief Executive Officer
06 Jun 2022 16:30:00 By Nasdaq GlobeNewswire
-
18 May 2022 06:45:00 By Nasdaq GlobeNewswire
-
12 May 2022 16:30:00 By Nasdaq GlobeNewswire